You are viewing the site in preview mode

Skip to main content
Fig. 3 | International Journal of Retina and Vitreous

Fig. 3

From: Use of a multifocal electroretinogram to evaluate the therapeutic effect of a single intravitreal dexamethasone implant, Ozurdex®, for refractory diabetic macular oedema

Fig. 3

Ring display of mfERG and CRT measured by OCT pre-DEX injection and post DEX injection at two, four and six months follow up periods. A: showed pre-DEX injection values of p1 amplitude of ring 1 measure 24.93 nV/deg2 and CRT 506 μm. B: same patient two months post DEX injection showed p1 amplitude of ring 1increased to 36.05 nV/deg2 and CRT decreased to 352 μm. C: same patient four months post DEX injection showed p1 amplitude of ring 1 measure 27.14 nV/deg2 and CRT 408 μm. D: same patient six months post DEX injection showed p1 amplitude of ring 1 measure 24.56 nV/deg2 and CRT 419 μm

Back to article page

International Journal of Retina and Vitreous

ISSN: 2056-9920

Contact us